The brain, AI, and mental health | Mariam Khayretdinova | TEDxBerlin Salon

Quick Overview

The discussion centers on the complexity of the human brain, particularly concerning neurodiversity and neurodegenerative diseases like Alzheimer's, highlighting the lack of sufficient data (like patient-specific brain data or global biobanks) needed for AI development in mental health compared to the vast data available for commercial products.

Key Points: The human brain is complex, exhibiting diversity across cultures, norms, values, and neurodiversity (ADHD, autism, etc.). Mariam Khayretdinova, a researcher from Oxford and Cambridge, shares her personal story of suffering from depression since age six, experiencing treatment resistance after trying ten different medications. The speaker criticizes the pharmaceutical industry for failing clinical trials for mental health conditions (e.g., 6% success rate for new medicines) while investing billions elsewhere, contrasting it with selling a can of Coca-Cola. Brain data collection for mental health research is severely lacking; there are no standard MRIs, EEGs, or blood tests for diagnoses like depression or Alzheimer's, forcing reliance on subjective symptom profiles. The speaker advocates for a communal effort, potentially involving regulators like the FDA, to build an international brain biobank with diverse data (ethnicity, gender, age) to facilitate accurate AI-driven diagnostics. The current system is described as 'broken' because of the disparity between the vast amount of commercial data available versus the scarce, non-personalized data available for brain health research.

Context: This video captures an interview segment from a TEDxBerlin Salon event themed "Connecting the Dots," featuring Mariam Khayretdinova, a researcher affiliated with Oxford and Cambridge, discussing the challenges in understanding and diagnosing brain health issues, particularly in the context of Artificial Intelligence (AI) development. The conversation begins with the moderator setting the stage by noting the diversity of human brains and introduces Khayretdinova's personal history with treatment-resistant depression, leading into a critique of current data collection practices in neuroscience and mental health research.